AdaptHealth (AHCO) Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AHCO shares.
View AHCO analyst ratings or view top-rated stocks.

7 equities research analysts have issued 1 year price targets for AdaptHealth's stock. Their AHCO share price forecasts range from $11.00 to $30.00. On average, they anticipate the company's stock price to reach $18.92 in the next twelve months. This suggests a possible upside of 121.3% from the stock's current price.
View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts.

AdaptHealth's stock was trading at $19.22 at the start of the year. Since then, AHCO stock has decreased by 55.5% and is now trading at $8.55.
View the best growth stocks for 2023 here.

AdaptHealth saw a drop in short interest in August. As of August 31st, there was short interest totaling 6,090,000 shares, a drop of 14.8% from the August 15th total of 7,150,000 shares. Based on an average trading volume of 1,340,000 shares, the short-interest ratio is currently 4.5 days. Approximately 7.2% of the company's shares are sold short.
View AdaptHealth's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our AHCO earnings forecast.

AdaptHealth Corp. (NASDAQ:AHCO) released its quarterly earnings data on Tuesday, August, 8th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.05. The firm earned $793.29 million during the quarter, compared to analyst estimates of $765.69 million. AdaptHealth had a trailing twelve-month return on equity of 3.03% and a net margin of 1.41%.

ETFs with the largest weight of AdaptHealth (NASDAQ:AHCO) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Janus Henderson Small Cap Growth Alpha ETF (JSML), Invesco S&P SmallCap Value with Momentum ETF (XSVM), Invesco S&P SmallCap Health Care ETF (PSCH), Harbor Small Cap Explorer ETF (QWST), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) and EA Bridgeway Omni Small-Cap Value ETF (BSVO).Syntax Stratified SmallCap ETF (SSLY).

AdaptHealth updated its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.16 billion-$3.20 billion, compared to the consensus revenue estimate of $3.14 billion.

Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS).

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

AdaptHealth's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (8.65%), Truist Financial Corp (2.91%), Reinhart Partners LLC. (2.27%), Rubric Capital Management LP (2.15%), State Street Corp (2.04%) and Silvercrest Asset Management Group LLC (1.28%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Albert A Prast, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends.

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AHCO stock can currently be purchased for approximately $8.55.

AdaptHealth (NASDAQ:AHCO) has a market capitalization of $1.16 billion and generates $2.97 billion in revenue each year. The company earns $69.32 million in net income (profit) each year or $0.12 on an earnings per share basis.

The company employs 10,900 workers across the globe.

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The official website for the company is www.adapthealth.com. The company can be reached via phone at (610) 424-4515 or via email at dsullivan@equityny.com.